Anti–IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis
Y Chen, CL Langrish, B Mckenzie… - The Journal of …, 2006 - Am Soc Clin Investig
IL-23 is a member of the IL-12 cytokine family that drives a highly pathogenic T cell
population involved in the initiation of autoimmune diseases. We have shown that IL-23 …
population involved in the initiation of autoimmune diseases. We have shown that IL-23 …
Interleukin-15 in autoimmunity
H Allard-Chamard, HK Mishra, M Nandi, M Mayhue… - Cytokine, 2020 - Elsevier
Abstract Interleukin-15 (IL-15) is a member of the IL-2 family of cytokines, which use receptor
complexes containing the common gamma (γ c) chain for signaling. IL-15 plays important …
complexes containing the common gamma (γ c) chain for signaling. IL-15 plays important …
Understanding the IL-23–IL-17 immune pathway
BS McKenzie, RA Kastelein, DJ Cua - Trends in immunology, 2006 - cell.com
Interleukin (IL)-23 is a heterodimeric cytokine closely related to IL-12. Yet, despite a strong
structural relationship that includes a shared p40 subunit, this does not translate into …
structural relationship that includes a shared p40 subunit, this does not translate into …
[HTML][HTML] Targeting interleukin-17 in chronic inflammatory disease: A clinical perspective
P Zwicky, S Unger, B Becher - Journal of Experimental Medicine, 2020 - rupress.org
Chronic inflammatory diseases like psoriasis, Crohn's disease (CD), multiple sclerosis (MS),
rheumatoid arthritis (RA), and others are increasingly recognized as disease entities, where …
rheumatoid arthritis (RA), and others are increasingly recognized as disease entities, where …
Divergent pro-and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation
CA Murphy, CL Langrish, Y Chen… - The Journal of …, 2003 - rupress.org
Interleukin (IL) 23 is a heterodimeric cytokine composed of a p19 subunit and the p40
subunit of IL-12. IL-23 affects memory T cell and inflammatory macrophage function through …
subunit of IL-12. IL-23 affects memory T cell and inflammatory macrophage function through …
The role of IL-17 in systemic lupus erythematosus and its potential as a therapeutic target
T Koga, K Ichinose, A Kawakami… - Expert review of clinical …, 2019 - Taylor & Francis
Introduction: Systemic lupus erythematosus (SLE) is an autoimmune disease characterized
by autoantibodies production and immune complex deposition with systemic clinical …
by autoantibodies production and immune complex deposition with systemic clinical …
Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapy
EP Bowman, AA Chackerian… - Current Opinion in …, 2006 - journals.lww.com
Summary Interleukin-12 and interleukin-23 have distinct roles in mediating host defense and
autoimmune inflammation. Although targeting interleukin-12 and interleukin-23 …
autoimmune inflammation. Although targeting interleukin-12 and interleukin-23 …
Pathogenic role of IL-17 and therapeutic targeting of IL-17F in psoriatic arthritis and spondyloarthropathies
G Sánchez-Rodríguez, L Puig - International Journal of Molecular …, 2023 - mdpi.com
The interleukin 17 (IL-17) family, a subset of cytokines consisting of IL-17A-F, plays crucial
roles in host defence against microbial organisms and the development of inflammatory …
roles in host defence against microbial organisms and the development of inflammatory …
[HTML][HTML] Revisiting the interleukin 17 family of cytokines in psoriasis: pathogenesis and potential targets for innovative therapies
NC Brembilla, WH Boehncke - Frontiers in Immunology, 2023 - frontiersin.org
Psoriasis is a common chronic inflammatory skin disease, associated with substantial
comorbidity. TH17 lymphocytes, differentiating under the influence of dendritic cell-derived …
comorbidity. TH17 lymphocytes, differentiating under the influence of dendritic cell-derived …
Mechanistic rationales for targeting interleukin-17A in spondyloarthritis
SP Raychaudhuri, SK Raychaudhuri - Arthritis research & therapy, 2017 - Springer
The term spondyloarthritis (SpA) is used to describe a group of inflammatory autoimmune
diseases, including ankylosing spondylitis and psoriatic arthritis, with common genetic risk …
diseases, including ankylosing spondylitis and psoriatic arthritis, with common genetic risk …